BostonGene Techologies

BostonGene is pioneering the use of biomedical software to identify novel and personalized treatment options through next-generation multi-platform analytics, advancing and optimizing outcomes for cancer patients.
We perform comprehensive integrated genomic (WES) and transcriptomic (RNA-seq) testing of tumors and tumor microenvironments, which equips doctors with actionable intelligence that helps identify individual treatment plans. Our mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics.